相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Pleiotropic Effects of the Hydroxy-Methyl-Glutaryl-CoA Reductase Inhibitors in Cardiovascular Disease A Comprehensive Review
Christos G. Mihos et al.
CARDIOLOGY IN REVIEW (2010)
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives
Qian Zhou et al.
CIRCULATION JOURNAL (2010)
Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular Disease
Benjamin Sadowitz et al.
VASCULAR AND ENDOVASCULAR SURGERY (2010)
Effect of Rosuvastatin on Coronary Atheroma in Stable Coronary Artery Disease Multicenter Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects (COSMOS)
Tadateru Takayama et al.
CIRCULATION JOURNAL (2009)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M. Ridker et al.
LANCET (2009)
AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells
Xiaoxia Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Benefit of adding pioglitazone to successful statin therapy in nondiabetic patients with coronary artery disease
Koichi Sugamura et al.
CIRCULATION JOURNAL (2008)
Statins activate peroxisome proliferator-activated receptor γ through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages
Miyuki Yano et al.
CIRCULATION RESEARCH (2007)
Statins activate AMP-activated protein kinase in vitro and in vivo
Wei Sun et al.
CIRCULATION (2006)
Effects of statins beyond lipid lowering: Potential for clinical benefits
K Almuti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Clinical implications for statin pleiotropy
JK Liao
CURRENT OPINION IN LIPIDOLOGY (2005)
Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition
CA Argmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis - In vivo study by high-resolution magnetic resonance imaging
R Corti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Modulation of inflammatory mediators and PPARγ and NFκB expression by pravastatin in response to lipoproteins in human monocytes in vitro
I Zelvyte et al.
PHARMACOLOGICAL RESEARCH (2002)
Structural mechanism for statin inhibition of HMG-CoA reductase
ES Istvan et al.
SCIENCE (2001)
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization
M Crisby et al.
CIRCULATION (2001)
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability
KK Koh
CARDIOVASCULAR RESEARCH (2000)
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Y Kureishi et al.
NATURE MEDICINE (2000)
分享论文
